Bioasis Technologies Inc.

BIOAFOTCHealthcare● Active

$0.00

$-0.00(-0.00%)

Market Cap$7941

P/E Ratio—

52W High$0.0002

52W Low$0.000099999997

Avg Volume1K

Open$0.00

Beta1.74

Overview

Bioasis Technologies Inc. (BIOAF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BIOAF · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2023Report Date: Jan 19, 2023

EPS Actual

-$0.01

Est. -$0.01 · +0.0%

Revenue

$0.00B

Fiscal Period

Q1 FY2023

FY ends December

Report Date

Jan 19, 2023

After Market Close

✓ 1-Quarter EPS Beat Streak

BIOAF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Aug 3, 2026	-$0.02	—	—	—	$0.00B	—
◌ Q2 FY2026	Apr 29, 2026	-$0.02	—	—	—	$0.00B	—
◌ Q2 FY2026	Apr 29, 2026	—	—	—	—	—	—
◌ Q1 FY2025	Feb 3, 2025	—	—	—	—	—	—
◌ Q4 FY2024	Oct 28, 2024	—	—	—	—	—	—
◌ Q3 FY2024	Jul 29, 2024	—	—	—	—	—	—
◌ Q2 FY2024	May 1, 2024	—	—	—	—	—	—
◌ Q1 FY2024	Jan 19, 2024	—	—	—	—	—	—

Q3 FY2026

Aug 3, 2026

EPS Actual

—

EPS Est.

-$0.02

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 29, 2026

EPS Actual

—

EPS Est.

-$0.02

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 29, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2025

Feb 3, 2025

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2024

Oct 28, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2024

Jul 29, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

May 1, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2024

Jan 19, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2028	$-0.01	$-0.01	$-0.01	1
Q2 FY2028	$-0.01	$-0.01	$-0.01	1
Q1 FY2028	$-0.01	$-0.01	$-0.01	1
Q4 FY2027	$-0.01	$-0.01	$-0.01	1
Q3 FY2027	$-0.01	$-0.01	$-0.01	1
Q2 FY2027	$-0.02	$-0.02	$-0.02	1

Revenue Estimates

Period	Low	Consensus	High	# Analysts
Q3 FY2028	$0.0B	$0.0B	$0.0B	1
Q2 FY2028	$0.0B	$0.0B	$0.0B	1
Q1 FY2028	$0.0B	$0.0B	$0.0B	1
Q4 FY2027	$0.0B	$0.0B	$0.0B	1
Q3 FY2027	$0.0B	$0.0B	$0.0B	1
Q2 FY2027	$0.0B	$0.0B	$0.0B	1

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q1 FY2023	Jan 19, 2023	+0.0%	$0.04	$0.03	-24.64%
— Q4 FY2022	Oct 28, 2022	—	$0.13	$0.13	+0.56%

Q1 FY2023-24.64%

Report Date

Jan 19, 2023

EPS Beat/Miss

+0.0%

Price Before

$0.04

Price After

$0.03

Q4 FY2022+0.56%

Report Date

Oct 28, 2022

EPS Beat/Miss

—

Price Before

$0.13

Price After

$0.13

Avg Beat Reaction-24.64%

Beat Rate1 / 2 quarters

Largest Move-24.64% (Q1 FY2023)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Bioasis Technologies Inc. (BIOAF) most recently reported earnings on January 19, 2023 for Q1 FY2023, posting EPS of $-0.01 (in line with the analyst consensus of $-0.01). The next BIOAF earnings date is expected around September 1, 2026.

Each quarter, investors track BIOAF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIOAF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

BIOAF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

BIOAF earnings · 4 questions

Bioasis Technologies Inc.'s next earnings report is expected around September 1, 2026. BIOAF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIOAF historically reports after market close (AMC).

BIOAF earnings datewhen is BIOAF earningsBIOAF next earnings datewhen does BIOAF report earningsBIOAF earnings calendar

▸ Source: FMP · Bioasis Technologies Inc. SEC filings · US GAAP · Bioasis Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026